First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1

201836 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov NCT02366013.

Good health and well-being

Published in: PLoS ONE

Volume 13, Issue 11, pp. e0205139-e0205139

Field-Weighted Citation Impact: 2.73